Such domino-triggering is also observed in APDS patients, from gain-of-function mutant p85 to p110 (Dornan et al., 2017), which similarly illustrates the fine-tuned nature of the PI3K/mTORC2/Akt signaling pathway. Here, AKT1 is linked to activated PI3K-delta syndrome.